Founded in 2020, Glimpse partners with brands to strategically place their products within luxury short-term rentals, serving as an innovative sales and acquisition channel.
Lumber is a technology company specializing in construction workforce management. It offers an automated platform that streamlines payroll, time tracking, accounts payable, compliance, and onboarding processes for construction businesses. The platform leverages artificial intelligence and automation to provide contractors with enhanced control over their operations and simplified finance management.
Patlytics
Series A in 2025 
Patlytics develops an artificial intelligence engine that automates various tasks in intellectual property workflows. Its platform streamlines processes such as building claim charts, patent-to-product mappings, asset classification, identifying valuable patents, invention disclosure submissions, and portfolio data comparison.
Latent Labs
Series A in 2025 
Latent Labs is a pioneering AI laboratory specializing in programmable biology. It develops advanced generative AI models that capture the core principles of biology, empowering healthcare partners to create novel antibodies, optimize existing enzymes, and advance genetic engineering. This enables partners to gain unparalleled control over molecular biology, driving transformative advancements in health and sustainability.
Coram AI develops video intelligence platforms for businesses. Their innovative approach transforms ordinary cameras into intelligent systems, providing insights into operations, security, and safety to drive improvements.
Overland AI
Series A in 2025 
Overland AI develops artificial intelligence-based autonomous navigation systems for off-road vehicles. Its modular software uses machine learning and robotic technologies, enabling autonomous operation in challenging terrains like mines, construction sites, and disaster zones, primarily serving defense and national security sectors.
Reveal Technology
Series A in 2024 
Reveal Technology is a visual analytics and edge artificial intelligence company that focuses on enhancing situational awareness for defense and public safety teams. The company has developed a platform that integrates advanced AI-driven technologies to deliver real-time two-dimensional and three-dimensional mapping and tactical insights. This technology enables operators to achieve decision dominance in mission-critical environments while also reducing emissions signatures. Through its innovative solutions, Reveal Technology aims to empower teams with the tools necessary for effective decision-making in complex situations.
Seen Health
Series A in 2024 
Seen Health operates a healthcare service focused on empowering older adults to age with dignity in their communities. It specializes in culturally-focused, technology-enabled services that integrate medical care and social support.
Even partners with top hospitals nationwide to offer unlimited diagnostics, consultations, and hospitalization coverage worth INR 50 lakhs via a single monthly subscription.
Companies rely on Numeric to ensure their financial data is accurate, automate the month-end close, and generate real-time insights.
Rated 4.9 / 5 on G2
Amber Therapeutics
Series A in 2024 
Amber Therapeutics specializes in developing advanced bioelectronic therapies that can sense and adapt, aiming to enhance clinical outcomes for patients with functional disorders of the peripheral nervous system.
iCOMAT specializes in automated composite manufacturing technology, pioneering the Rapid Tow Shearing (RTS) process. This patented method enables defect-free fiber steering for composites, allowing customers across aerospace, automotive, and marine sectors to produce lighter, stronger, and more cost-effective products. iCOMAT's unique capability to optimize mechanical properties by steering fiber paths reduces material usage and production costs.
Luminate Medical
Venture Round in 2024 
Luminate Medical specializes in developing innovative medical devices aimed at preventing hair loss during chemotherapy. Recognizing the significant impact of hair loss on patients' self-esteem, the company focuses on utilizing advanced medical technology to protect this essential element of personality.
Latus Bio
Series A in 2024 
Latus Bio is a biotechnology company dedicated to developing innovative gene therapies for neurological diseases. It specializes in novel discovery approaches using non-human primate models, enabling precise delivery of therapeutic genes to targeted cells within the central nervous system. Latus Bio aims to enhance clinical safety and manufacturing efficiency by administering low doses of its proprietary adeno-associated virus (AAV) capsids.
Amae Health
Series A in 2024 
Amae Health is a clinic specializing in mental wellness care for individuals with severe mental illnesses. It offers tailored treatments across behavioral medicine, primary care, and social health services, aiming to stabilize patients, enhance their well-being, and prevent future crises. The company's integrated care platform is designed to address the unique needs of its patients, enabling improved health outcomes.
Edia Learning
Series A in 2024 
Edia is an EdTech platform for 6-12 Math that ensures superior state test outcomes.
Campus is an accredited online community college dedicated to providing accessible higher education through its online learning services. The institution offers a range of associate degree and certificate programs, delivered both live online and in person. Campus prioritizes student success by making community college education available nationwide, ensuring that students have the flexibility and support needed to achieve their educational goals.
Lightbeam.ai
Series A in 2024 
LightBeam.ai is a leading innovator in data security and privacy automation, dedicated to helping organizations manage and access sensitive data securely. The company's platform utilizes advanced data management techniques, including entity linkage and deep learning, to efficiently scan and comprehend documents, speech, and natural language processing at scale. This technology operates seamlessly across various third-party virtual clouds or managed services, allowing clients to integrate data from diverse sources and generate actionable insights while safeguarding data privacy and confidentiality. LightBeam.ai empowers privacy and compliance executives to maintain continuous compliance, while also providing information security executives with assurance that sensitive data is accessed and utilized securely. Through its identity-centric discovery and classification engine, LightBeam integrates data cataloging, access, and sharing into a cohesive privacy control system.
Harbor Health
Series A in 2024 
Founded in 2022, Harbor Health is a multi-specialty clinic group based in Austin, Texas. It offers personalized healthcare through technology, co-creating health paths tailored to individuals' goals with specialist guidance when needed.
Cambium is a company focused on developing biomaterials for various sectors, including defense, aerospace, and renewable energy. Established in 2019 and located in Berkeley, California, it specializes in advanced materials research and development. The company utilizes a combination of synthetic biology, materials science, and artificial intelligence to enhance material performance and sustainability. Cambium's approach involves vertically integrated innovation, ranging from computational material discovery to the production of advanced composites within the United States. By leveraging cutting-edge advancements across multiple scientific disciplines, Cambium aims to improve existing products and facilitate the creation of next-generation materials.
Samara is a home services company that specializes in home renovation, interior design, and architectural services. The firm operates a design studio aimed at enhancing living spaces by offering customized solutions for clients. Samara focuses on building homes and creating tailored backyards that accommodate studios and bedrooms, allowing clients to fully personalize their residences. Through its various services, the company seeks to improve the quality of living for its customers by transforming their homes into functional and aesthetically pleasing environments.
Saronic Technologies
Series A in 2023 
Saronic Technologies specializes in the design and manufacture of advanced unmanned surface vehicles (USVs). These vehicles are equipped with cutting-edge hardware, software, and artificial intelligence, creating a scalable and integrated platform for enhancing maritime security and domain awareness. Tailored for defense and surveillance applications, Saronic's products offer comprehensive operational capabilities to naval and maritime forces.
Reserv is a developer of a digital claims third-party administrator platform designed to optimize property and casualty claims. The platform is compliant with insurance carriers and also serves as an incubator to test technologies and AI services to advance claims innovation and efficiency, enabling users to access products and services that deliver better outcomes and address critical resource challenges.
Endear Health
Series A in 2023 
Endear Health is a technology company focused on addressing the healthcare needs of the aging population. It provides an online platform that serves as a single access point for Medicare-eligible individuals, enabling them to effectively manage their health and benefits. The platform is designed to be user-friendly, offering tools that help seniors collect and organize their health-related information. By doing so, Endear Health aims to empower older adults to overcome barriers in healthcare and take control of their health management.
Vital Bio
Venture Round in 2023 
Vital Bio is focused on transforming lab testing to make healthcare more accessible and personalized. The company develops advanced diagnostic technologies that integrate devices, software, and services to support patients in monitoring their health and managing diseases. By bridging the gap between diagnosis and treatment, Vital Bio aims to empower patients and healthcare providers alike, promoting proactive care and reducing disparities in health outcomes. The company's innovative approach seeks to enhance the overall healthcare experience, ensuring that individuals have greater control over their health management.
DataHub Core is the #1 open source platform with a uniquely scalable and extensible metadata graph supporting manual and automated data management. DataHub Cloud is an enterprise-ready SaaS solution providing a fully-managed service of DataHub Core with additional AI-powered capabilities in discovery, observability, and governance to accelerate production-readiness of AI and data assets.
Myeloid Therapeutics
Series A in 2023 
Myeloid Therapeutics is an immunology company dedicated to leveraging innovative technologies to harness the potential of myeloid cells for the treatment of cancer and other diseases. The company has developed the ATAK platform, which focuses on reprogramming innate immune cells to enhance their ability to target and eliminate cancerous cells. Initially, Myeloid Therapeutics is advancing a cell therapy program aimed at treating T cell lymphoma, as well as a primed monocyte strategy for glioblastoma. The versatility of the ATAK platform allows for scalability across various treatment modalities and disease areas, facilitating collaboration with partners to expand its applications in the field of immunotherapy.
Empassion Health
Venture Round in 2023 
Founded in 2022, Empassion Health specializes in providing comprehensive care services for patients with advanced illnesses. The company offers community-based care management tools and services, including patient enrollment, primary care visits, urgent care, goals planning, and social support, enabling patients to optimize their daily lives and maintain independence at home.
Chaos Industries
Series A in 2023 
Chaos Industries is a technology company focused on defense and critical industries, developing advanced sensing, detection, and communication capabilities. It leverages Coherent Distributed Networks to enhance sensing, detection, and communication across platforms and emphasizes time synchronization to enable highly mobile, scalable, and cost-efficient systems. The company delivers integrated, software-defined solutions for defense, government, and industrial applications in challenging environments.
Atomic AI
Series A in 2023 
Atomic AI is a company focused on advancing drug discovery through the innovative integration of machine learning and structural biology, specifically targeting RNA. The firm operates a content intelligence platform that facilitates the rational design of new molecules and medicines using artificial intelligence. By leveraging engagement data from clients' analytics, Atomic AI gathers valuable insights and generates predictive reports regarding relevant topics, optimal publishing times, and effective distribution channels. This approach equips users with strategies to develop therapies aimed at treating or curing diseases through the manipulation of RNA structures.
Oula Health
Series A in 2023 
Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.
Mantra Bio
Series A in 2023 
Mantra Bio, Inc. is a biotechnology company focused on developing targeted therapeutics through its proprietary platform for engineering Targeted Exosome Vehicles (TEVs). Founded in 2016 and based in San Francisco, California, the company utilizes its REVEAL platform, which integrates computational biology, wet lab techniques, and automation. This innovative approach leverages the diversity of exosomes to design and optimize therapeutics aimed at various tissue and cellular targets. Mantra Bio has also established a scalable biomanufacturing process to ensure the reproducibility and high purity of its next-generation therapeutics, enabling medical practitioners to address challenging diseases effectively.
Second Front Systems
Series A in 2022 
Second Front Systems develops software that facilitates government access to innovative commercial technologies for national security missions. Its flagship product, Atlas Fulcrum, enables identification, assessment, and secure deployment of these technologies. The company also offers program management services and High Technology Council, an enterprise consortium fostering collaboration between market players.
Telegraph
Series A in 2022 
Telegraph is a Chicago-based company founded in 2020 that focuses on transforming the freight rail industry through its innovative cloud-based operating system. This platform enhances collaboration among railroads, shippers, and third-party logistics providers, allowing for improved visibility and insights into rail operations. By leveraging advanced technology, Telegraph aims to streamline workflows and logistics, ultimately fostering a more sustainable supply chain in the freight ecosystem. Its modern approach seeks to facilitate commerce and improve efficiency in rail operations, marking a significant advancement for the industry.
Surge Therapeutics
Series A in 2022 
SURGE Therapeutics is a biotechnology company focused on enhancing cancer treatment outcomes through innovative immunotherapy solutions. It has developed a proprietary injectable biodegradable hydrogel designed to deliver cancer therapeutics in a prolonged and localized manner. This technology enables targeted release of immunotherapy agents at the surgical site following tumor resection, allowing for more effective treatment administration. By optimizing the timing and location of drug delivery, SURGE Therapeutics aims to improve patient survival rates and minimize systemic side effects, representing a significant advancement in the field of cancer care.
Invisible AI
Series A in 2022 
Invisible AI is a computer vision company that provides an edge-based, no-code visual intelligence platform and cameras for manufacturing and logistics facilities. Its low-bandwidth cameras are deployed at workstations to monitor real-time human motion, enabling accurate, safe, and efficient operations. The platform integrates with a web dashboard to deliver visibility, data analysis, and built-in intelligence that helps optimize quality, productivity, safety, and workflows. The system captures movements of the workforce to surface actionable insights on staffing, safety, and process efficiency, delivering real-time visibility into operational practices.
Jacobi develops a technology platform offering customizable tools for modeling and visualizing multi-asset portfolios. Its platform streamlines investment processes, facilitates portfolio design and analysis, and enhances client engagement through intuitive dashboards.
Opto Investments
Series A in 2022 
Opto Investments is a private equity firm based in New York, established in 2020. The company provides a comprehensive platform designed for independent investment advisors, enabling them to access private market investments. Opto connects these advisors with top-performing managers and offers a full suite of alternative asset tools, accompanied by expert insights. This approach aims to enhance revenue generation for clients while facilitating access to private investment opportunities, ultimately supporting long-term wealth building.
Rephrase.ai
Series A in 2022 
Rephrase.ai develops AI-powered video creation technology. It transforms any given text into photorealistic videos of people speaking that content, enabling clients to produce training videos, personalized sales videos, AR/VR characters, and digital assistants.
Harbor Health
Series A in 2022 
Founded in 2022, Harbor Health is a multi-specialty clinic group based in Austin, Texas. It offers personalized healthcare through technology, co-creating health paths tailored to individuals' goals with specialist guidance when needed.
Photys Therapeutics
Series A in 2022 
Photys Therapeutics is a biopharmaceutical company focused on developing bifunctional small molecules that provide precise control over protein post-translational modifications. This innovative platform allows for the restoration of protein function, repair of cellular signaling pathways, and enhancement of the body's natural disease-fighting abilities. Co-founded by prominent chemist Amit Choudhary from the Broad Institute and the Longwood Fund, Photys is supported by a scientific advisory board that includes renowned experts from institutions such as MIT, Salk Institute, and Berkeley. The company's unique approach aims to advance therapeutic options in the healthcare industry, particularly by targeting kinases and potentially phosphatases, to address various diseases effectively.
KeyCare is a virtual care platform that leverages the Epic system to support health systems in enhancing patient access and quality of care. The platform is designed to provide a tech-driven virtual care team that supplements existing healthcare workforces, thereby broadening the options available for virtual care. By focusing on increasing accessibility and improving care quality, KeyCare aims to meet the needs of patients and healthcare providers in a rapidly evolving healthcare landscape.
Cartography Biosciences
Series A in 2022 
Cartography Biosciences specializes in developing precision cancer immunotherapies. It employs single-cell analysis to identify novel targets for Chimeric Antigen Receptor T-cell (CAR-T) therapies, aiming to enhance safety and efficacy.
Fruitful is a financial membership platform designed to help Americans understand, organize, and optimize their finances. It offers one-on-one financial guidance tailored to members' unique lifestyles and goals, along with stress-free saving, spending, and investing features. Fruitful partners members with supportive Certified Financial Planners™ who provide ongoing advice and investment strategies at a fraction of the cost of traditional advisory firms.
Felux is a B2B marketplace and supply chain platform specifically designed for the mining industry. The company provides a comprehensive suite of services that includes procurement solutions and supply chain management. Its platform facilitates the buying and selling of industrial products, allowing users to source, procure, ship, finance, and analyze transactions related to steel and other materials in one centralized location. This digital approach enables suppliers to efficiently manage their selling and distribution processes while enhancing commerce within the industrial sector.
Seaplane IO
Series A in 2022 
Seaplane IO Inc. is a technology company that specializes in developing a serverless cloud software system tailored for modern enterprises. Founded in 2020 and headquartered in Mountain View, California, Seaplane IO enables developers to create and scale applications globally without the complexities of managing cloud infrastructure. The company's platform supports on-premises and cloud server deployments, allowing for secure code execution from any location. By harnessing the capabilities of multi-cloud and edge computing, Seaplane IO provides the necessary APIs, services, and support to help software developers deliver optimal application performance to users worldwide.
Candid Health
Series A in 2022 
Candid Health is a platform that automates revenue cycle management for healthcare providers by integrating with existing infrastructure and using machine learning and artificial intelligence to streamline medical billing, coding, and claims processing. It delivers end-to-end automation to reduce administrative burdens, increase operational efficiency, and accelerate reimbursement, enabling clinics and hospitals to focus more on delivering high-quality, affordable care.
Fieldguide
Series A in 2022 
Fieldguide, Inc. is an enterprise software company that specializes in automation and collaboration solutions for audit and advisory firms. Established in 2020 and based in Sacramento, California, Fieldguide's platform digitizes the entire project lifecycle, offering features such as secure data requests, work plan management, reporting automation, and resource planning. The software utilizes artificial intelligence to standardize templates and streamline data management, facilitating efficient report creation. By enhancing workflow processes, Fieldguide aims to help firms improve margins, attract new business, and strengthen client relationships, ultimately empowering productivity and revenue growth in the assurance and advisory sectors.
Founded in 2021 by former Salesforce HR team members Thanh Nguyen and Nancy Connery, OpenComp empowers high-growth companies with compensation intelligence. Its platform enables over 2,000 companies to attract and retain top talent fairly and consistently. OpenComp's tool helps businesses analyze how changes in compensation structure impact cash and equity burn, facilitating accurate benchmarking by gender and ethnicity.
Standard Metrics
Series A in 2022 
Standard Metrics is a platform that automates financial data management for venture capital teams and their portfolio companies. It provides real-time access to firm-wide data, enabling investors and founders to make informed decisions.
180° Insurance
Series A in 2022 
180° is an InsurTech company that provides insurance services. With a focus on the B2B2C model, the company builds insurance and assistance products with technology that are connected to customers' daily lives in a simple and digital way.
180° was founded in 2020 and is headquartered in Sao Paulo, Brazil.
Cellino develops scalable, automated biomanufacturing systems for personalized cell therapies based on induced pluripotent stem cells (iPSCs). The company aims to enable potentially curative, patient-specific treatments by producing autologous iPSCs at scale and applying AI-guided, image-driven laser processing and robotics to remove unwanted cells. By integrating image-guided machine learning, single-cell laser processing, and robotics, Cellino seeks to enhance precision, efficiency, and scalability in optical bioprocessing, accelerating the development of regenerative therapies for chronic degenerative diseases such as vision loss and Parkinson's disease.
Rocketlane
Series A in 2022 
Rocketlane is a software company offering a professional services automation and client onboarding platform designed to streamline onboarding and collaborative project delivery for customer engagements. The platform enables transparent and consistent execution by supporting client collaboration on projects, time tracking, AI-assisted resource management, and project accounting, which improves visibility and governance. By shortening time to value, Rocketlane helps professional services teams deliver onboarding and implementation projects efficiently and provide a positive, repeatable onboarding experience for customers across industries.
Ritten
Venture Round in 2022 
Ritten specializes in providing an electronic medical records platform tailored for addiction treatment providers. Its platform offers customizable workflow configurations to ensure consistent, compliant care delivery, enabling clinicians and administrators to maintain comprehensive patient records that track clinical notes, medications, and treatment plans, thereby facilitating personalized, data-informed care.
Software.com
Series A in 2021 
Software.com is an online retailer of software solutions located in Manhattan Beach, California. As a subsidiary of Internet Real Estate Group, LLC, the company focuses on transforming software development by quantifying the craft through data collection across various stages of the development process. By providing insights and analytics, Software.com aims to assist developers and teams in improving productivity and coding efficiency.
Petra is a robotics company specializing in underground utility solutions. The firm has developed advanced tunneling robots designed to efficiently and safely bore utility conduits through various geological conditions, including high-grade hard rock. By enabling the undergrounding of critical utilities, Petra provides a practical and cost-effective means to construct small-diameter infrastructure, particularly in disaster-prone areas. Their technology addresses the challenges of traditional tunneling methods, making it feasible to install essential utilities in previously inaccessible locations.
Founded in 2017 by Dr. Matthew Hill, Elegen is a biotechnology company specializing in microfluidic technology for the development of advanced DNA synthesizers. Its mission is to accelerate biomedical progress through innovative synthetic biology solutions.
SurgLogs Inc. is a software developer based in San Diego, California, specializing in compliance-related solutions for ambulatory surgery centers and healthcare facilities. Founded in 2015, the company provides a digital platform that replaces traditional pen-and-paper methods with a HIPAA-compliant application and an administrative dashboard. This platform organizes and automates the management of logbooks, medications, supplies, in-services, and drills, enhancing efficiency and reducing paperwork for healthcare organizations. SurgLogs offers features such as device authorization, automated daily checks and notifications, and electronic report export services, catering to doctors, nurses, and healthcare administrators. By streamlining compliance processes, SurgLogs enables its clients to maintain regulatory standards effectively and manage operations more efficiently.
Quince, LLC, established in 2016 and headquartered in San Francisco, California, is a retailer specializing in affordable luxury apparel, accessories, and home goods. The company offers a wide range of products for men and women, including jewelry, clothing, and home textiles, all sourced directly from manufacturers using a just-in-time production model. This approach enables Quince to provide high-quality items at competitive prices while minimizing waste.
Spartan Radar
Series A in 2021 
Spartan Radar develops software algorithms that enhance radar sensing capabilities. Leveraging machine learning and edge-processing, its technology mimics human focus to safely respond to obstacles. It improves resolution, response time, and range of existing ADAS sensors at an affordable cost with minimal computational overhead.
Better Health
Series A in 2021 
Better Health is a digital platform facilitating peer-to-peer support and supplies management for individuals with chronic conditions such as ostomy, wounds, diabetes, retention, and incontinence. Trusted by major healthcare payers and providers, it improves patient outcomes and reduces care costs through education, engagement, and adherence.
Mindbloom
Series A in 2021 
Mindbloom is a mental health and wellness platform that provides at-home, clinician-prescribed psychedelic therapies, including guided ketamine sessions, to help individuals address anxiety and depression and improve overall well-being. The service pairs clients with licensed clinicians who review health history to determine suitability and guide treatment, ensuring physician oversight. The platform combines science-backed medicines designed by psychiatrists with behavioral science-based engagement and personalized media to support personal growth and sustained well-being. Mindbloom serves individual users and enterprise partners, and pursues research collaborations with academic institutions to advance understanding of digital and psychedelic therapies.
Esper is a company that specializes in developing a policy collaboration platform aimed at enhancing the policymaking process within government entities. By providing software that allows government officials to integrate, manage, and analyze policy data, Esper facilitates transparent and data-driven decision-making. The company collaborates with numerous government agencies, including the New York City Police Department, Washington Department of Health, and California State Treasurer’s Office, to streamline internal workflows and support the entire policymaking lifecycle. With a workforce of over 30 employees, Esper has raised more than $14 million in funding to further its mission of creating a unified source of truth for public policy.
Formlogic
Series A in 2021 
Formlogic is an autonomous manufacturing technology company focused on delivering precision components for the space and frontier industries. By addressing the challenges of the domestic supply chain, Formlogic enhances manufacturing capabilities, allowing both novice and expert workers to achieve high levels of precision and productivity. The company's technology enables rapid turnaround times for custom machined components, with production orders completed in weeks rather than months. Additionally, Formlogic provides real-time order status updates, improving the overall customer experience. Through its innovative approach, Formlogic aims to revolutionize the manufacturing process, ensuring close tolerances and efficient production at scale.
Appia Bio
Series A in 2021 
Appia Bio is a biotechnology company dedicated to the research and development of off-the-shelf allogeneic cell therapies, with a particular focus on engineered allogeneic cell therapies for various medical indications. The company utilizes its proprietary ACUA technology platform to harness the biology of lymphocyte development, integrating chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering. This innovative approach allows Appia Bio to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes derived from hematopoietic stem cells (HSCs). By maturing and scaling healthy stem cells into invariant T-cell therapies, Appia Bio aims to provide physicians with safe and targeted cancer treatment options, thereby expanding patient access to advanced therapeutic solutions.
Seed Health
Series A in 2021 
Seed Health is a biotechnology company focused on therapeutics, consumer health innovations, and environmental solutions grounded in microbial sciences. It collaborates with academic researchers to advance discoveries in microbiology and develops health supplements that employ live biotherapeutics, combining probiotics and prebiotics to support digestive health, skin health, heart health, and micronutrient synthesis.
PollyEx, Inc. operates a loan trading platform focused on the mortgage capital markets, facilitating transactions between buyers and sellers of mortgage loans. Founded in 2017 and based in San Francisco, California, PollyEx enhances loan sale execution through its cloud-based platform, which integrates with buyers and sellers via API, thereby increasing liquidity and automating various functions within capital markets. The platform aims to provide pricing transparency and improve operational efficiency for lenders, enabling them to make informed decisions throughout the lifecycle of a loan.
Polly is an anonymous polling application that allows users to create and share polls on social media platforms like Snapchat and Instagram. The app enables users to formulate questions and attach them to their stories, facilitating honest feedback from friends. By providing a fun and interactive way to gauge opinions, Polly encourages user engagement and fosters social interaction through its uniquely designed features.
Baton Trucking, Inc. is a logistics company based in San Francisco, California, that specializes in enhancing long-haul trucking efficiency through its innovative drop zone network. This network allows for the segmentation of long routes, facilitating the use of specialized vehicles for different sections of the journey. Additionally, Baton provides a real estate infrastructure designed for highway-only autonomous trucks to seamlessly interchange loads with human drivers for final-mile delivery. Incorporated in 2019, the company also operates a technology innovation laboratory that collaborates with Ryder System, focusing on a digital platform that utilizes optimization and artificial intelligence to streamline freight networks and reduce waste in trucking operations.
Elemy is a nationwide provider of childhood behavioral and mental healthcare, specializing in autism care since its launch in April 2020. The company has expanded its services to address a range of developmental and mental health issues, including ADHD, OCD, depression, and social anxiety. Elemy employs a technology-driven care model that modernizes traditional systems by offering in-home and online Applied Behavior Analysis (ABA) services. This approach enhances accessibility and clinical outcomes while reducing costs. The platform features free autism assessments and matches children with therapists to create individualized treatment plans tailored to their specific needs. Elemy's multidisciplinary clinical team oversees an integrated care model, demonstrating significant improvements in behavior for many children.
Edgybees Ltd. is a technology company based in Palo Alto, California, founded in 2016. It specializes in developing an innovative platform that delivers real-time augmented reality experiences for high-speed applications, including drones, vehicles, and wearable devices. The platform utilizes sensors and streaming data to enable application developers to create immersive overlays that maintain synchronization with high-speed motion. Edgybees offers a range of industrial solutions tailored for sectors such as search and rescue, homeland security, real estate, construction, agriculture, and automotive. Additionally, the company provides gaming applications, including Droneprix AR and Sky Skreemers. With its unique, patent-pending capabilities and a developer SDK, Edgybees facilitates the creation of both commercial and consumer applications, enhancing the effectiveness of operations for military and emergency responders.
BigHat Biosciences
Series A in 2021 
BigHat Biosciences is a biotechnology company that develops an AI-guided platform for designing and characterizing antibodies and other therapeutic proteins. The platform combines a wet laboratory with artificial intelligence and machine learning to enable antibody discovery and optimization, helping drug developers create antibodies and novel biotherapeutic designs. It emphasizes multi-objective, data-driven workflows to improve safety, biophysical properties, and efficacy of antibody candidates. Founded in 2019 and based in San Carlos, California.
Raydiant Inc., established in 2017 and headquartered in San Francisco, specializes in designing, developing, and providing an experience platform that connects employees and customers with brands across various industries such as banking, retail, hospitality, and healthcare. The company's solution comprises kiosks, virtual agents, and multimedia devices for screen management, enabling businesses to create engaging in-store experiences through digital signage. Raydiant works with over 5,000 brands worldwide, including notable clients like Johnson & Johnson and Chick-Fil-A, helping them streamline operations, enhance customer experiences, and drive sales growth.
Myeloid Therapeutics
Series A in 2021 
Myeloid Therapeutics is an immunology company dedicated to leveraging innovative technologies to harness the potential of myeloid cells for the treatment of cancer and other diseases. The company has developed the ATAK platform, which focuses on reprogramming innate immune cells to enhance their ability to target and eliminate cancerous cells. Initially, Myeloid Therapeutics is advancing a cell therapy program aimed at treating T cell lymphoma, as well as a primed monocyte strategy for glioblastoma. The versatility of the ATAK platform allows for scalability across various treatment modalities and disease areas, facilitating collaboration with partners to expand its applications in the field of immunotherapy.
Kojo is a cloud-based construction management software company that provides an all-in-one platform for contractors to manage their material and inventory needs. Founded in 2018 and based in San Francisco, Kojo's system focuses on streamlining materials management and procurement processes, enhancing profitability for construction companies. By integrating various stakeholders, including field teams, procurement, and distributors, Kojo simplifies the supply chain through automation, facilitating the ordering and tracking of materials. This approach enables contractors to ensure timely delivery of materials to job sites, thereby improving operational efficiency.
Cellares Corporation, founded in 2019 and based in South San Francisco, California, specializes in the development of cell therapies for cancer treatment. The company addresses significant manufacturing challenges associated with these therapies, which are often produced on a per-patient basis, leading to high costs and limited availability. Cellares is pioneering the Cell Shuttle, an automated, closed end-to-end manufacturing solution designed to enhance the scalability and efficiency of cell therapy production. This innovative system allows for the simultaneous production of ten times more patient doses compared to traditional manual methods, while also reducing process failure rates by three-fold and lowering manufacturing costs by up to 70 percent. By providing flexible and scalable manufacturing options, Cellares aims to accelerate the delivery of life-saving therapies to patients in need and support the broader biopharmaceutical industry in meeting global demand for these treatments.
Twingate Inc. is a technology company founded in 2018 and based in Redwood City, California, specializing in secure remote access solutions for organizations. The company offers a cloud-based platform designed to replace traditional Virtual Private Networks (VPNs) with a modern zero trust approach, which enhances security while maintaining usability for IT teams and end users. Twingate's technology enables employees to access private applications, data, and environments seamlessly, whether these resources are hosted on-premise or in the cloud. Key features include resource-level control, a centralized web-based administration console, split tunneling, and intelligent routing, all of which facilitate secure connections without the complexities associated with traditional deployment methods.
Dren Bio is a biotechnology company that specializes in protein engineering technologies aimed at depleting pathogenic cells, protein aggregates, and other disease-causing agents. The company operates under a holding business model, developing a diverse portfolio of projects that function as stand-alone assets. Dren Bio's platform is designed to address a range of health conditions, including hematologic neoplasms, solid tumors, autoimmune disorders, and diseases associated with protein aggregation. By focusing on innovative protein-based technologies, Dren Bio enables healthcare professionals to manage and treat various serious diseases more effectively.
Sonoma Pharmaceuticals
Series A in 2020 
Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company based in Woodstock, Georgia, focused on developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, dermatology, animal health, eye care, and oral care. With over 100 products commercialized in 33 countries, Sonoma addresses unmet medical needs through its innovative therapies aimed at chronic skin conditions. Key offerings include Epicyn, an antimicrobial facial cleanser; Levicyn, a prescription product for dermatoses; Celacyn gel for scar management; and SebuDerm for seborrheic dermatitis. Additionally, the company provides Microcyn, which targets various pathogens to promote wound healing, and Acuicyn, designed for eye care. Sonoma Pharmaceuticals was formerly known as Oculus Innovative Sciences, Inc. and has been incorporated since 1999. Its commitment to improving patient care and reducing healthcare costs is reflected in its diverse product portfolio that caters to both prescription and non-prescription needs.
Sonoma Biotherapeutics
Series A in 2020 
Sonoma Biotherapeutics, Inc. is focused on developing adoptive T regulatory (Treg) cell therapies aimed at treating autoimmune and degenerative diseases. Established in 2019 and based in South San Francisco, California, with an additional office in Seattle, the company employs next-generation genome editing and target-specific cell therapy techniques to innovate in the field of Treg cell therapeutics. The firm aims to create disease-modifying and potentially curative therapies that promote self-tolerance and inhibit harmful inflammatory responses associated with conditions such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer's disease. Founded by experts in Treg biology and cell therapy, Sonoma Biotherapeutics integrates advanced methodologies to enhance its therapeutic offerings.
Hexagon Bio
Series A in 2020 
Hexagon Bio, Inc. is a biotechnology company that specializes in discovering novel small molecule therapeutics by mining genomic data from fungal genomes. Founded in 2016 and headquartered in Menlo Park, California, Hexagon Bio leverages a proprietary platform that integrates data science, synthetic biology, and automation to identify and engineer drugs. The company's innovative approach focuses on developing targeted therapies for diseases with unmet medical needs by searching for evolutionarily refined molecules and their associated protein targets. Through its unique methodology, Hexagon Bio aims to uncover new medicines encoded within the global metagenome, ultimately striving to improve patient outcomes.
Sirona Medical
Series A in 2020 
Founded in San Francisco, Sirona Medical develops a cloud-native platform designed specifically for radiologists. This platform unifies worklist, viewer, reporter, archive, and AI into a single workspace, simplifying complex workflows, enhancing productivity, and empowering practitioners to deliver better, faster care.
Founded in 2019, Habi is a technology-driven real estate company headquartered in Bogotá, Colombia. It simplifies the homeownership lifecycle for middle-class customers throughout Latin America by providing a proprietary pricing algorithm and platform that enables faster and more efficient buying and selling of homes.
High Definition Vehicle Insurance
Series A in 2020 
HDVI is a technology-first commercial insurance provider. The company assesses risk using historical and real-time telematics data and provides tools and services that help fleets increase safety, rewards safe driving, and delivers efficient and fair claims processing. HDVI is headquartered in Chicago with additional offices in Greenville, South Carolina; Columbus, Ohio; Portland, Oregon; Dallas and San Francisco. High Definition Vehicle Insurance, Inc. is a licensed property casualty insurance agent with products underwritten by various insurance companies. For more information, visit https://hdvi.com.
Mantra Bio
Series A in 2020 
Mantra Bio, Inc. is a biotechnology company focused on developing targeted therapeutics through its proprietary platform for engineering Targeted Exosome Vehicles (TEVs). Founded in 2016 and based in San Francisco, California, the company utilizes its REVEAL platform, which integrates computational biology, wet lab techniques, and automation. This innovative approach leverages the diversity of exosomes to design and optimize therapeutics aimed at various tissue and cellular targets. Mantra Bio has also established a scalable biomanufacturing process to ensure the reproducibility and high purity of its next-generation therapeutics, enabling medical practitioners to address challenging diseases effectively.
Founded in 2018 by Fraser Robinson and Dmitri Izmailov, Beacon is a digital supply chain platform headquartered in London. It optimizes supply chains with insights and visibility, offering freight forwarding services across all modes integrated with its end-to-end visibility platform. This provides transparency and efficiency in goods movement, while the secure cloud-based software improves accuracy and saves time.
Hearth is a financial technology platform that supports home improvement contractors in growing and managing their businesses. The company offers a comprehensive suite of financial tools designed to facilitate business transactions, including financing advice, invoicing, payment collection, and insurance products. By enabling contractors to send quotes, contracts, invoices, and financing options from any location, Hearth streamlines the process of closing deals, ensuring a seamless experience for both contractors and clients.
Octant Bio
Series A in 2020 
Octant Bio is a company focused on developing synthetic technology to enhance health and treat diseases. The firm employs synthetic biology, genome engineering, next-generation sequencing, and computational tools to measure the activity of thousands of receptor pathways in human cells simultaneously. This approach allows scientists to use machine learning methods to engineer small molecules that can interact with multiple receptors, offering new potential for treating complex diseases.
Unlearn.AI
Series A in 2020 
Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.
Motherly, Inc. is a digital platform that focuses on supporting millennial mothers throughout their parenting journey, from conception to college. Established in 2015 and based in Menlo Park, California, the company provides a wealth of resources including articles, videos, and guides that cover diverse topics such as parenting advice, wellness tips, and lifestyle content. The platform offers information on various aspects of motherhood, including child-rearing, self-care, home management, beauty, and career coaching. Additionally, Motherly sells a range of products aimed at mothers, including registry essentials and holiday items. The company, formerly known as Motherly Media, Inc., rebranded in March 2018 to better reflect its mission of redefining motherhood and fostering a community-driven lifestyle brand.
MycoWorks
Series A in 2020 
MycoWorks is a biotechnology company specializing in the production of non-plastic and non-animal materials. Utilizing fungal mycelium, they create energy-efficient and biodegradable alternatives to plastic foams, textiles, woods, and leather for various industries such as aerospace, automotive, apparel, and architecture.
Sonoma Biotherapeutics
Series A in 2020 
Sonoma Biotherapeutics, Inc. is focused on developing adoptive T regulatory (Treg) cell therapies aimed at treating autoimmune and degenerative diseases. Established in 2019 and based in South San Francisco, California, with an additional office in Seattle, the company employs next-generation genome editing and target-specific cell therapy techniques to innovate in the field of Treg cell therapeutics. The firm aims to create disease-modifying and potentially curative therapies that promote self-tolerance and inhibit harmful inflammatory responses associated with conditions such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer's disease. Founded by experts in Treg biology and cell therapy, Sonoma Biotherapeutics integrates advanced methodologies to enhance its therapeutic offerings.
Legalpad Inc. is a Seattle-based company that provides a platform designed to streamline the work visa application process, particularly for startups. Founded in 2018 by Sara Itucas, Legalpad focuses on automating repeatable legal tasks and workflows, primarily addressing the complexities associated with O-1, EB-1, H-1B, and B-1 visas. The platform combines intelligent software with human support to facilitate easier and faster visa applications, helping employers and employees navigate the legal landscape of international employment. By connecting global talent with opportunities, Legalpad aims to simplify the legal processes required for individuals seeking to work across borders.
Xilis
Venture Round in 2019 
Xilis, Inc. is a biotechnology company founded in 2019 and based in Chapel Hill, North Carolina. The company specializes in developing next-generation organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. Its flagship platform, XilisµO, facilitates rapid diagnostics, personalized drug screening, and the creation of scalable patient-derived models, which support high-throughput drug discovery. By enabling both physicians and pharmaceutical companies to conduct tailored drug screenings, Xilis aims to lower costs and improve treatment outcomes for cancer patients.
Nines is a pioneering teleradiology practice that focuses on enhancing patient care through advanced technology. The company develops in-house tools that empower radiologists to provide high-quality diagnostics. Its platform is designed to analyze medical scans for urgent findings that necessitate immediate attention, as well as to identify subtle details that assist in the radiological review process. This innovative approach aims to improve the accuracy of results and overall patient care, setting Nines apart in the field of radiology.
Epirus
Venture Round in 2019 
Epirus, Inc. is a technology company based in Hawthorne, California, specializing in the design and development of advanced defense systems that utilize artificial intelligence and directed energy. Founded in 2018, the company focuses on creating solid-state, software-defined high-power microwave solutions aimed at countering unmanned aircraft systems and other asymmetric threats. Its flagship product, ELECTROMAGNETIC PULSE, serves as a counter-infrastructure solution that can simultaneously target multiple threats, effectively neutralizing drones and swarms. By integrating AI and machine learning with advanced electronics, Epirus enhances the detection and tracking of objects of interest, offering innovative capabilities in electronic warfare and power management for both defense and commercial sectors.
Jacobi develops a technology platform offering customizable tools for modeling and visualizing multi-asset portfolios. Its platform streamlines investment processes, facilitates portfolio design and analysis, and enhances client engagement through intuitive dashboards.